KR930000508A - 2-아미노피리미딘-4-카르복시아미드 유도체 그 제법 및 치료에의 이용 - Google Patents

2-아미노피리미딘-4-카르복시아미드 유도체 그 제법 및 치료에의 이용 Download PDF

Info

Publication number
KR930000508A
KR930000508A KR1019920011216A KR920011216A KR930000508A KR 930000508 A KR930000508 A KR 930000508A KR 1019920011216 A KR1019920011216 A KR 1019920011216A KR 920011216 A KR920011216 A KR 920011216A KR 930000508 A KR930000508 A KR 930000508A
Authority
KR
South Korea
Prior art keywords
group
general formula
compound
hydrogen atom
methoxy
Prior art date
Application number
KR1019920011216A
Other languages
English (en)
Korean (ko)
Inventor
조르류 파스칼
마누리 필립쁘
마라부 브느와
프루와쌍 쟈끄
메를리 쟝-삐에르
Original Assignee
에. 뚜레 레메뜨르
신떼라보 쏘시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에. 뚜레 레메뜨르, 신떼라보 쏘시에떼 아노님 filed Critical 에. 뚜레 레메뜨르
Publication of KR930000508A publication Critical patent/KR930000508A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
KR1019920011216A 1991-06-27 1992-06-26 2-아미노피리미딘-4-카르복시아미드 유도체 그 제법 및 치료에의 이용 KR930000508A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9107939 1991-06-27
FR9107939A FR2678272B1 (fr) 1991-06-27 1991-06-27 Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
KR930000508A true KR930000508A (ko) 1993-01-15

Family

ID=9414359

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920011216A KR930000508A (ko) 1991-06-27 1992-06-26 2-아미노피리미딘-4-카르복시아미드 유도체 그 제법 및 치료에의 이용

Country Status (23)

Country Link
US (1) US5244894A (es)
EP (1) EP0520883B1 (es)
JP (1) JP3159526B2 (es)
KR (1) KR930000508A (es)
CN (1) CN1067885A (es)
AT (1) ATE124935T1 (es)
AU (1) AU644295B2 (es)
CA (1) CA2072433A1 (es)
CZ (1) CZ9202003A3 (es)
DE (1) DE69203402T2 (es)
DK (1) DK0520883T3 (es)
ES (1) ES2077998T3 (es)
FI (1) FI922982A (es)
FR (1) FR2678272B1 (es)
GR (1) GR3017249T3 (es)
HU (1) HUT61749A (es)
IE (1) IE922094A1 (es)
IL (1) IL102332A0 (es)
MX (1) MX9203333A (es)
NO (1) NO922525L (es)
NZ (1) NZ243340A (es)
PL (1) PL295045A1 (es)
ZA (1) ZA924785B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0598046T3 (da) * 1991-08-14 1999-05-25 Procter & Gamble Pharma Hidtil ukendte urinstoffer egnede som antiarrytmi- og antifibrilleringsmidler
DK0577470T3 (da) * 1992-07-03 1995-10-02 Synthelabo 2-amino-N(((4-(aminocarbonyl)pyrimidin-2-yl)amino)alkyl) pyrimidin-4-carboxamid-derivater, deres fremstilling og deres anvendelse i terapi
FR2703355B1 (fr) * 1993-03-29 1995-05-05 Synthelabo Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
FR2744722B1 (fr) * 1996-02-14 1998-03-13 Synthelabo Devires de 2-((3-(piperazin-1-yl)propyl)amino)pyrimidine-4- carboxamide et leur application en therapeutique
WO1999057131A1 (en) 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
JP2008504279A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
AU2005258248A1 (en) * 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
US7687665B2 (en) * 2004-06-24 2010-03-30 Incyte Corporation 2-methylprop anamides and their use as pharmaceuticals
EA200700117A1 (ru) 2004-06-24 2007-06-29 Инсайт Корпорейшн N-замещенные пиперидины и их применение в качестве фармацевтических препаратов
MX2007001540A (es) * 2004-08-10 2007-04-23 Incyte Corp Compuestos amido y sus usos como farmaceuticos.
CA2872883A1 (en) * 2012-05-09 2013-11-14 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2143730A1 (de) * 1971-09-01 1973-03-08 Byk Gulden Lomberg Chem Fab Substituierte pyridine, verfahren zu deren herstellung und sie enthaltende arzneimittel
FR2656609B1 (fr) * 1989-12-28 1992-03-27 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2678271B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de pyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
MX9203333A (es) 1993-02-01
CZ9202003A3 (en) 1993-01-13
HUT61749A (en) 1993-03-01
FI922982A (fi) 1992-12-28
FR2678272B1 (fr) 1994-01-14
HU9202143D0 (en) 1992-10-28
IL102332A0 (en) 1993-01-14
IE922094A1 (en) 1992-12-30
ES2077998T3 (es) 1995-12-01
NO922525L (no) 1992-12-28
CN1067885A (zh) 1993-01-13
FR2678272A1 (fr) 1992-12-31
DK0520883T3 (da) 1995-12-11
AU1858892A (en) 1993-01-07
ATE124935T1 (de) 1995-07-15
JP3159526B2 (ja) 2001-04-23
DE69203402D1 (de) 1995-08-17
NO922525D0 (no) 1992-06-26
FI922982A0 (fi) 1992-06-26
EP0520883B1 (fr) 1995-07-12
JPH05186435A (ja) 1993-07-27
ZA924785B (en) 1993-03-31
PL295045A1 (en) 1993-03-08
EP0520883A1 (fr) 1992-12-30
CA2072433A1 (en) 1992-12-28
GR3017249T3 (en) 1995-11-30
DE69203402T2 (de) 1996-03-07
AU644295B2 (en) 1993-12-02
US5244894A (en) 1993-09-14
NZ243340A (en) 1994-02-25

Similar Documents

Publication Publication Date Title
KR930000508A (ko) 2-아미노피리미딘-4-카르복시아미드 유도체 그 제법 및 치료에의 이용
DK114783A (da) Hidtil ukendte forbindelser, fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
KR920021517A (ko) 중축 신경계에 활성인 신규의 3-아미노피리다진 유도체, 그의 제조방법 및 이들의 존재하는 약제학적 조성물
SE8104781L (sv) Heterocykliska foreningar
NO800447L (no) Derivater av difenylhydantoin, farmasoeytiske preparater inneholdende slike preparater, samt fremgangsmaate til fremstilling av de aktive forbindelser
DE3786118T2 (de) Aminoalkylthio-Triazolopyridin- oder Triazolochinolinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Arzneimittel, brauchbar als Antalgikum.
KR900003156A (ko) 진통제 화합물, 그의 제조방법 및 그를 함유하는 약학 조성물
SE7501365L (es)
KR890017244A (ko) 6-페닐-3-(피페라지닐알킬)-2,4-(1h,3h)-피리미딘디온 유도체, 그의 제법 및 치료에의 이용
DK326481A (da) Fremgangsmaade til fremstilling af i 5-stillingen substituerede 5,10-dihydro-11h-dibenzo (b,e) (1,4) diazepin-11-oner eller syreadditionssalte deraf
KR840004726A (ko) 5-하이드록시트립타민 길항제인 퀴놀린 유도체의 제조방법 및 그 제약조성물
KR880001614A (ko) 콜린 수용체의 효능약인 신규의 트리시클릭 유도체 및 그를 함유하는 약물
DK19182A (da) Fremgangsmaade til fremstilling af phenylpiperazinyl-propaner af heterylphenoler
KR880013934A (ko) 시네르지스틴 및 그 염과 이들의 제조방법 및 이들을 포함하는 제약학적 조성물
DK154891C (da) Analogifremgangsmaade til fremstilling af thieno-thiazolderivater og deres fysiologisk acceptable syreadditionssalte.
KR960007566A (ko) 신규한 퀴놀릴아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도
DE3866292D1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ES8501382A1 (es) Procedimiento para la preparacion de derivados de acido fenilacetico.
ES469456A1 (es) Procedimiento para la produccion de o-propiloximas sustitui-das con restos basicos.
SE8005493L (sv) 4-(haftalenyloxi)piperidin-derivat
ATE22081T1 (de) Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
DE69102309T2 (de) N-cycloalkyl-Alkylamine, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und Zwischenprodukte zu ihrer Synthese.
KR930000501A (ko) 피리디닐피페라진 유도체
CO4810228A1 (es) Derivados de pirazol piridazina, procesos para su preparacion y composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid